BimatoprostThird Party Manufacturing in India

Bimatoprost works by mimicking the activity of naturally occurring prostamides to increase the outflow of aqueous humor through both the trabecular meshwork and uveoscleral pathways. It targets the prostanoid FP receptors to help the body effectively reduce intraocular pressure and stimulate hair follicle growth. Unlike alternative topical antiglaucoma drugs, it offers superior 24-hour intraocular pressure control with single daily dosing. It is highly effective and well-tolerated.

Therapeutic Uses

• Open-Angle Glaucoma: Prescribed to lower intraocular pressure in patients suffering from open-angle glaucoma.
• Ocular Hypertension: Used to control elevated fluid pressure inside the eyes to prevent long-term optic nerve damage.
• Hypotrichosis of the Eyelashes: Applied topically to the eyelid margin to increase eyelash growth, length, thickness, and darkness.

Why Manufacturers Choose Bimatoprost

Bimatoprost third party manufacturing in India represents a highly profitable opportunity across both ophthalmic and aesthetic medical sectors. Due to its dual utility in glaucoma management and cosmetic eyelash enhancement, market demand remains consistently elevated. Celesta facilitates manufacturing through specialized partner facilities that are WHO-GMP certified, utilizing strict aseptic filling technology to maintain product integrity. Offering this premium molecule under WHO-GMP standards allows brands to target high-margin B2B and consumer pharmaceutical segments.